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Abstract
Background: Excessive oxidative stress and lipid peroxidation have been demonstrated to play important roles in
the production of liver damage. L-carnitine is a natural substance and acts as a carrier for fatty acids across the
inner mitochondrial membrane for subsequent beta-oxidation. It is also an antioxidant that reduces metabolic
stress in the cells. Recent years L-carnitine has been proposed for treatment of various kinds of disease, including
liver injury. This study was conducted to evaluate the protective effect of L-carnitine against hydrogen peroxide
(H2O2)-induced cytotoxicity in a normal human hepatocyte cell line, HL7702.
Methods: We analyzed cytotoxicity using MTT assay and lactate dehydrogenase (LDH) release. Antioxidant activity
and lipid peroxidation were estimated by reactive oxygen species (ROS) levels, activities and protein expressions of
superoxide dismutase (SOD) and catalase (CAT), and malondialdehyde (MDA) formation. Expressions of peroxisome
proliferator-activated receptor (PPAR)-alpha and its target genes were evaluated by RT-PCR or western blotting. The
role of PPAR-alpha in L-carnitine-enhanced expression of SOD and CAT was also explored. Statistical analysis was
performed by a one-way analysis of variance, and its significance was assessed by Dennett’s post-hoc test.
Results: The results showed that L-carnitine protected HL7702 cells against cytotoxity induced by H2O2. This
protection was related to the scavenging of ROS, the promotion of SOD and CAT activity and expression, and the
prevention of lipid peroxidation in cultured HL7702 cells. The decreased expressions of PPAR-alpha, carnitine
palmitoyl transferase 1 (CPT1) and acyl-CoA oxidase (ACOX) induced by H2O2 can be attenuated by L-carnitine.
Besides, we also found that the promotion of SOD and CAT protein expression induced by L-carnitine was blocked
by PPAR-alpha inhibitor MK886.
Conclusions: Taken together, our findings suggest that L-carnitine could protect HL7702 cells against oxidative
stress through the antioxidative effect and the regulation of PPAR-alpha also play an important part in the
protective effect.
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Background
L-carnitine (L-3-hydroxy-4-N-N-N-trimethylaminobuty-
rate) is an essential nutrient that the body uses to con-
vert fat into energy. It acts as a carrier for fatty acids
across the inner mitochondrial membrane for subse-
quent b-oxidation [1]. It is also an antioxidant that
reduces metabolic stress in the cells. Studies have
reported that L-carnitine have an effective 1,1-diphenyl-
2-picryl-hydrazyl (DPPH) free radical scavenging, super-
oxide anion radical scavenging, hydrogen peroxide
scavenging, and total reducing power [2].
Recent years L-carnitine has been proposed for treat-
ment of various kinds of disease, including liver injury.
Several studies have shown that L-carnitine administra-
tion can ameliorate or prevent liver damage of various
etiologies. Animal studies showed that dietary
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any medium, provided the original work is properly cited.supplementation with L-carnitine could prevent hepatitis
and subsequent hepatocellular carcinoma in Long-Evans
Cinnamon rats [3] and alleviate alcohol-induced liver
damage in rats [4]. In addition, some experimental and
clinical data suggested that early intravenous supple-
mentation with L-carnitine could improve survival in
severe valproic acid -induced hepatotoxicity [5]. In vitro,
L-carnitine has been successfully used to delay the kill-
ing of cultured rat hepatocytes by 1-Methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP) [6].
Reactive oxygen species (ROS) are considered to be
involved in liver damage induced by several conditions
such as alcohol abuse, fibrosis/cirrhosis of various etiol-
ogies, hepatocellular carcinoma (HCC), ischemia/reper-
fusion (I/R) liver injury, paracetamol overdose, and viral
hepatitis [7]. Therefore, prevention or impairment of
oxidative stress constitutes a therapeutic target to be
achieved for hepatoprotection. Different antioxidant
strategies have shown to be useful to reduce oxidative
stress and cell death in hepatocytes [8]. Recently, Dobr-
zyńska et al. found that L-carnitine protected liver cell
membranes against oxidative modifications in ethanol-
intoxicated rats through its ability to scavenge free radi-
cals [9]. Therefore, antioxidant activity of L-carnitine
m a ym a k ei tp l a yar o l ei nt h et r e a t m e n to fl i v e r
diseases.
Peroxisome proliferator-activated receptors (PPARs)
are ligand-activated transcription factors belonging to
the nuclear hormone receptor superfamily and are
involved in energy homeostasis [10]. It consists of three
members: PPAR-a, PPAR-g,a n dP P A R - b/δ.P P A R - a is
distributed in metabolically active tissues including liver,
most prominently in hepatocytes [10,11]. PPAR-a has a
central role in fatty acid oxidation, lipid and lipoprotein
metabolism, inflammatory responses, and oxidative
stress [12]. It was reported that PPAR-a
/mice fed etha-
nol developed marked hepatomegaly, steatohepatitis,
liver cell death and proliferation, and portal fibrosis [13].
PPAR-a ligands, such as Wy-14,643, were reported to
have an antifibrotic action in the rat thioacetamide
(TAA) model of liver cirrhosis [14]. In addition, L-carni-
tine treatment has been found to be able to elevate
PPAR-a activation in renal tubular cells and plays a cru-
cial role in L-carnitine anti-apoptosis effect [15]. There-
fore, we hypothesize that PPAR-a may mediated the
hepatoprotective effect of L-carnitine.
Our work undertaken was to determine whether L-
carnitine exerts cytoprotective properties against ROS-
induced cell death in cultured human hepatocytes and
explores the mechanisms. For this purpose, normal
human hepatocyte HL7702 was treated by H2O2,w h i c h
was the major component of ROS and has been exten-
sively used as an inducer of oxidative stress models.
Methods
Reagents and drugs
L-carnitine, H2O2,M T T ,2 ’,7’-dichlorfluorescein-diace-
tate (DCFH-DA) and MK886 were purchased from
Sigma-Aldrich (St Louis, MO, USA). Superoxide dismu-
tase (SOD), catalase (CAT), and malonaldehyde (MDA)
assay kits were all purchased from Nanjing Jiancheng
Bioengineering Institute (Nanjing, China). Antibodies
against PPAR-a, SOD1, and CAT were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-
b-actin antibody was purchased from Boisynthesis Bio-
technology (Beijing China). All the other reagents used
were of analytical grade.
Cells culture and treatment
Human normal hepatocyte cell line HL7702 used in this
study was purchased from the Shanghai Institute of Cell
Biology, Chinese Academy of Sciences (Shanghai,
China). Cells were cultured in RPMI 1,640 medium sup-
plemented with 10% fetal calf serum, 100 U/ml penicil-
lin, and 100 μg/ml streptomycin, and maintained at 37°
Ci n5 %C O 2 incubator.
To estimate the effects of L-carnitine, HL7702 cells
were pretreated with various concentrations of L-carni-
tine for 12 h before exposed to H2O2.T h e n ,t h em e d -
ium was replaced with serum-free medium and 300 μM
H2O2 was added. Control cells were received serum-free
medium without H2O2. The cells were incubated in this
condition for another 12 h.
Cell viability analysis
Cell viability was analyzed by MTT assay. Briefly,
HL7702 cells were cultured in 96-well plates at a density
of 1 × 10
4 cells/well for 24 h. L-carnitine at different
concentrations (0.01 ~ 5 mM) was added and preincu-
bated for 12 h before exposed to H2O2.A f t e rH 2O2
treatment as described, the medium was removed and
cells were washed twice with PBS. Then, MTT (0.5 mg/
ml) was added to each well and incubation for 4 h at
37°C. Finally, medium was removed and 150 μl dimethyl
sulfoxide (DMSO) was added to each well. The plate
was read using a microplate reader (Thermo Scientific,
Waltham, MA, USA) at a wavelength of 570 nm.
Measurement of lactate dehydrogenase (LDH) release
HL7702 cells were first plated in 24-well plates for 24 h.
L-carnitine (0.1, 0.5, and 1 mM) was then added to the
wells and preincubated for 12 h before exposed to
H2O2.A f t e rH 2O2 treatment, aliquots of culture med-
ium were taken out for extracellular LDH activity analy-
sis. Intracellular LDH activity was determined after lysis
by addition of 1% Triton X-100. LDH activity was
detected by automatic biochemical analyzer (Mindray,
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ing to manufacturer’s protocol. LDH release represents
the percentage of LDH in the culture medium relative
to the total LDH.
Intracellular reactive oxygen species (ROS) measurement
The fluorescent probe DCFH-DA was used to detect the
intracellular ROS. DCFH-DA diffuses into cells and is
hydrolyzed to form non-fluorescent 2’,7’-dichlorodihy-
drofluorescein (DCFH). DCFH is then oxidised by ROS
to form the highly fluorescent 2’,7’-dichlorofluorescein.
Following H2O2 treatment, cells were collected by cen-
trifugation, resuspended in serum-free medium contain-
ing 10 μM DCFH-DA, incubated for 30 min at 37°C,
washed with PBS to remove unreacted dye, resuspended
in PBS and was detected at 485 nm excitation and at
535 nm emission using flow cytometry.
Measurement of superoxide dismutase (SOD), catalase
(CAT) activity and malondialdehyde (MDA) level
After H2O2 treatment, cells were resuspended in 50 mM
Tris buffer containing 0.5% Triton X-100, pH 8.0, and
lysed by freeze-thawing. Lysates were centrifuged at
5,000 × g for 10 min at 4°C and the supernatant
obtained was used for the following measurements. The
total SOD, CAT activities and MDA levels were deter-
mined spectrophotometrically using assay kits according
to manufacturer’s instructions. The protein content of
the supernatant was determined using the Bradford
method.
Western blot analysis
PPAR-a, SOD1, and CAT protein expressions in
HL7702 cells were analyzed by Western blot. Total cel-
lular protein was extracted in lysis buffer and protein
levels were quantified using a BCA (bicinchoninic acid)
Protein Assay kit (Beyotime Biotechnology, Haimen,
China). Aliquots containing 30 μg proteins were loaded
on to a 12% SDS-polyacrylamide gel. After electrophor-
esis, proteins were transferred to a nitrocellulose mem-
brane. The membrane was probed with antibodies
against PPAR-a, SOD1, CAT or b-actin. The membrane
was then processed with HRP conjugated goat anti-rab-
bit IgG (Boisynthesis Biotechnology, Beijing, China).
Protein bands were visualized using the diamino-benzi-
dine detection kit. The densities of sample bands were
analyzed with Quantity One analysis software.
Reverse transcriptase-PCR
After treatment, total RNA was extracted from HL7702
cells using Trizol reagent (Biomed, Beijing, China),
according to the manufacturer’s protocol. Reverse tran-
scription to cDNA was carried out with All-in-One™
First-Strand cDNA Synthesis Kit (GeneCopoeia, USA)
with oligo-dT primer in a final volume of 25 μla t4 2 ° C
for 1 h. PCR was performed using PCR Master Mix kit
(Fermentas, USA) in a final volume of 50 μl. The pri-
mers used were as follows: ACT CAA CAG TTT GTG
GCA AGA CA and GGA AGC ACG TCC TCA CAT
GA for PPAR-a (119 bp) [16]; GGA GAG GAG ACA
G A CA C CA T CC Aa n dC A AA A TA G GC C TG A C
GAC ACC TG for CPT1 (244 bp) [17]; TGT CCT ATT
TGA ACG ACC TGC CCA and AGG TTC CAA GCT
ACC TCC TTG CTT for ACOX (199 bp) [18]; CGT
GGA AGG ACT CAT GAC CA and TCC AGG GGT
CTT ACT CCT TG for GAPDH (509 bp). Specific PCR
products were visualized by agarose electrophoresis.
Assessment of the amount of target gene mRNA expres-
sion was performed comparatively using GAPDH
mRNA as a control.
Statistical analysis
Statistical analysis was performed by a one-way analysis
of variance (ANOVA), and its significance was assessed
by Dennett’s post-hoc test. Data are presented as mean
± standard deviation (SD), and a value of P <0 . 0 5w a s
considered statistically significant.
Results
L-carnitine protected HL7702 cells against H2O2-induced
cytotoxicity
Cell viability was evaluated by MTT assay. To determine
the cytotoxicity of L-carnitine and what concentrations
of L-carnitine may exert a cytoprotective effect on
H2O2-induced toxicity in HL7702 cells, dose-viability
curves were generated, as shown in Figure 1.
The upper curve in Figure 1 showed that, coincubated
with L-carnitine, concentrations ranging from 0.01 to 3
mM, cell growth were not be affected significantly,
while at a higher concentration of 5 mM, a significant
inhibitory effect of L-carnitine was observed (P < 0.05).
This finding suggests that the toxicity of L-carnitine
increases after 3 mM.
The lower curve in Figure 1 showed that, after expo-
sure to 300 μMH 2O2 for 12 h, HL7702 cells displayed
markedly decreased viability compared to untreated
ones. Doses of L-carnitine ranging from 0.1 to 3 mM
significantly reduced the cell viability loss, and a dose-
dependent manner was found from 0.1 to 1 mM, we
thus decided to use 0.1 ~ 1 mM for all subsequent
experiments.
L-carnitine inhibited H2O2-induced LDH release in HL7702
cells
The integrity of cell membrane was determined by the
release of LDH. Figure 2 showed that there was a low
LDH leakage ratio under normal conditions. However,
H2O2 induced significant LDH release. Pretreatment
Li et al. Journal of Biomedical Science 2012, 19:32
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LDH release in a dose-dependent manner.
L-carnitine promoted endogenous antioxidant defense in
HL7702 cells under oxidative stress
SOD, CAT activities and protein levels were measured
to investigate the antioxidative effect of L-carnitine on
H2O2-damaged HL7702 cells. The activity was expressed
as U/mg protein in cells. Compared with the control
group, the activities of total SOD and CAT in the H2O2
alone group were decreased by 30.05% and 38.25%
respectively (Figure 3A). Compared to H2O2-damaged
cells, 0.5 ~ 1 mM L-carnitine reversed the activities of
SOD and CAT. Western blot analysis showed that H2O2
exposure resulted in a marked decrease of Cu,Zn-SOD
and CAT protein levels in HL7702 cells, while L-carni-
tine pretreatment significantly elevated the protein levels
(Figure 3B).
L-carnitine scavenged H2O2-induced ROS production in
HL7702 cells
To determine whether L-carnitine prevents H2O2-
induced ROS generation, the concentration of intracel-
lular ROS was evaluated by the changes in DCF fluores-
cence intensity. The result showed that DCF
fluorescence intensity dropped significantly from 23.1 ±
2.0 in cells treated with H2O2 only to values between
16.9 ± 1.3 and 12.8 ± 1.3 in cells to which 0.1 ~ 1 mM
L-carnitine was added (Figure 4).
L-carnitine inhibited lipid peroxidation in H2O2-damaged
HL7702 cells
The ability of L-carnitine to inhibit lipid peroxidation in
H2O2-treated HL7702 cells was also tested by determin-
ing MDA levels. As shown in Figure 5, the exposure of
cells to H2O2 increased MDA levels by approximately
1.7 fold relative to control cells. An obvious dose-depen-
dent reduction of L-carnitine on MDA levels in H2O2-
treated cells was observed.
L-carnitine up-regulated PPAR-a expression in H2O2-
damaged HL7702 cells
We further analyzed the effect of L-carnitine on PPAR-
a mRNA and protein expressions in H2O2-treated
HL7702 cells. As shown in Figure 6, treatment of
HL7702 cells with 300 μMH 2O2 for 12 h reduced the
PPAR-a mRNA and protein levels in HL7702 cells.
When the cells were preincubated with L-carnitine
before H2O2 exposure, PPAR-a expression increased
markedly compared to H2O2 alone group, although the
mRNA expression was not significantly changed in 0.1
mM L-carnitine group.
To assess if the elevated PPAR-a expression by L-car-
nitine leads to induction of PPAR-a-regulated genes in
H2O2-treated HL7702 cells, we examined mRNA levels
of CPT1 and ACOX by RT-PCR. Exposure to H2O2
caused inhibition of the mRNA expression of CPT1 and
ACOX. L-carnitine, on the other hand, attenuated the
inhibitory effect of H2O2.
L-carnitine increases SOD and CAT expression in H2O2-
damaged HL7702 cells via PPAR-a expression
Activation of PPAR-a by agonists has been previously
shown to enhance SOD expression and CAT activity in
Figure 1 The cytotoxicity of L-carnitine and its protective
effect on H2O2-induced toxicity in HL7702 Cells. The upper
curve: HL7702 cells were incubated with L-carnitine for 24 h. The
lower curve: Cells were treated with or without L-carnitine prior to
H2O2 challenge (300 μM, 12 h). Cell viability was assayed by MTT
assay. The percentage of cell viability in the control group was
treated as 100%. Each value represents the mean of three replicates.
ΔP < 0.05,
#P < 0.01 vs. control; *P < 0.05, **P < 0.01 vs.H 2O2 alone.
Figure 2 Effect of L-carnitine on the LDH release of HL7702
cells. Cells were treated with or without L-carnitine prior to H2O2
challenge (300 μM, 12 h). LDH release represents the percentage of
LDH in the culture medium relative to the total LDH. Each value
represents the mean of three replicates.
#P < 0.01 vs. control; *P <
0.05, **P < 0.01 vs.H 2O2 alone;
ΔP < 0.05 vs. 0.1 mM L-carnitine;
▲P
< 0.05 vs. 0.5 mM L-carnitine.
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Page 4 of 9Figure 3 Effect of L-carnitine on the activities andp r o t e i ne x p r e s s i o n so fS O Da n dC A Ti nH 2O2-damaged HL7702 cells. Cells were
treated with L-carnitine for 12 h and followed by the treatment of H2O2 (300 μM) for 12 h. A: Total SOD and CAT activities were calculated in
units of activity per mg of total protein. B: Cu,Zn-SOD and CAT expressions were determined by western blot analysis. Results were expressed as
the ratio of expression level of Cu,Zn-SOD or CAT over b-actin. Each value represents the mean of three replicates.
#P < 0.01 vs. control; *P <
0.05, **P < 0.01 vs.H 2O2 alone.
Figure 4 Effect of L-carnitine on intracellular ROS levels after H2O2 exposure in HL7702 cells. Cells were treated with or without L-
carnitine prior to H2O2 challenge (300 μM, 12 h). ROS levels were measured using fluorescent probe DCFH-DA. Each value represents the mean
of three replicates.
#P < 0.01 vs. control; **P < 0.01 vs.H 2O2 alone.
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vated SOD and CAT expression induced by L-carnitine
was due to enhanced levels of PPAR-a, a specific
antagonist of PPAR-a,M K 8 8 6 ,w a su s e d .M K 8 8 6( 5
μM) was added to cells 2 h prior to H2O2 insult. As
s h o w ni nF i g u r e7 ,M K 8 8 6d i dn o ta l t e rS O Da n dC A T
protein levels in control cells. However, the up-regula-
tion of SOD and CAT expression by L-carnitine was
inhibited by addition of MK886 in H2O2-treated cells.
Discussion
H2O2 is a major component of ROS produced intracel-
lularly during many physiological and pathological pro-
cesses, and causes oxidative damage. It has been
extensively used as an inducer of oxidative stress in
vitro models. Our results showed that 300 μMH 2O2
exposure for 12 h induced a significantly decreased cell
growth and elevated LDH leakage in HL7702 cells. L-
carnitine at a concentration of 0.1 to 3 mM showed no
harmful effects on the growth of HL7702 cells, however,
cell growth was inhibited by 5 mM L-carnitine. The
possibility may be that high doses of carnitine possess
pro-oxidant activity as has been reported [21]. Our
results demonstrated the protective effects of 0.1 ~ 3
mM L-carnitine against the inhibition of cell growth
induced by H2O2. LDH leakage was also inhibited by 0.1
~ 1 mM L-carnitine in a dose-dependent manner. These
findings suggest that L-carnitine is capable of reducing
H2O2-induced cytotoxicity in HL7702 cells.
Oxidative stress after H2O2 exposure results from
intracellular ROS production and decreased ROS
scavenging. To further explore the mechanism of the
protective effect of L-carnitine on H2O2-induced oxida-
tive damage in HL7702 cells, we examined the effect of
L-carnitine on intracellular ROS production. H2O2 chal-
lenge caused an apparent increase in ROS levels in
HL7702 cells compared to control group, however, in
vitro treatment with L-carnitine resulted in reduced
ROS levels. Scavenging of ROS is determined by antioxi-
dant enzymes such as SOD and CAT. CAT is consid-
ered to be the most relevant enzyme involved in
detoxification of H2O2 and protection of hepatocytes
from oxidative stress [22]. We observed that the inhib-
ited activities and expressions of SOD and CAT induced
by H2O2 were attenuated by L-carnitine. These observa-
tions supported the idea that L-carnitine did protect
HL7702 cells from H2O2-induced cytotoxicity by its
antioxidant property.
Liver damage was associated with enhanced lipid per-
oxidation and formation of lipid radicals [23,24]. MDA,
as an end product of lipid peroxidation, usually used to
estimate the extent of lipid peroxidation. It has been
shown that many pathological conditions that resulted
in elevation of MDA due to lipid peroxidation were pre-
vented by L-carnitine [25,26]. In our paper, MDA levels
in HL7702 cells increased after H2O2 exposure. How-
ever, pretreatment with L-carnitine (0.1 ~ 1 mM) pre-
vented a further increase in MDA levels.
H2O2, a low molecular weight compound, can easily
penetrate lipid membrane, cause lipid peroxidation, and
disturb lipid homeostasis. PPAR-a is a ligand-dependent
transcription factor that is known to have critical roles in
the regulation of lipid homeostasis. It has been reported
that PPAR-a expression decreased in a rat model of non-
alcoholic fatty liver disease [27] and the absence of
PPAR-a have been demonstrated to cause lipid accumu-
lation in liver of rats [28]. Our results showed that
HL7702 cells exposed to 300 μMH 2O2 for 12 h showed
a significant reduction in PPAR-a expression levels, indi-
cating the disturbed lipid homeostasis might occur in
H2O2-damaged HL7702 cells. However, L-carnitine pre-
treatment attenuated the inhibitory effect of H2O2 on the
expression of PPAR-a. It is well known that expression
of a range of genes involved in lipid homeostasis is con-
trolled by PPAR-a, which binds to the peroxisome prolif-
erator response element (PPRE) in the promoters of
these genes [29]. Therefore, mRNA expression of CPT1
and ACOX, two PPAR-a target genes that control fatty
acid oxidation [30,31], were also investigated. Results
showed that the repression of CPT1 and ACOX expres-
sion induced by H2O2 were all attenuated by L-carnitine.
Above observations indicate that the disturbed lipid
homeostasis induced by H2O2 might be ameliorated by
L-carnitine by increasing PPAR-a expression. In fact, as
we know, L-carnitine acts as a carrier participate in fatty
acids b-oxidation. So, the attenuated lipid metabolism in
H2O2-damaged HL7702 cells would be significantly ame-
liorated by L-carnitine. This observation is consistent
Figure 5 Effect of L-carnitine on H2O2-induced MDA formation
in HL7702 cells. Cells were treated with or without L-carnitine prior
to H2O2 challenge (300 μM, 12 h). Each value represents the mean
of three replicates.
#P < 0.01 vs. control; *P < 0.05, **P < 0.01 vs.
H2O2 alone;
ΔP < 0.05 vs. 0.1 mM L-carnitine;
▲P < 0.05 vs. 0.5 mM L-
carnitine.
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supplementation induced recovery of liver lipid metabo-
lism in cachectic animals [32]. Furthermore, it is likely
that the enhancement of b-oxidation induced by L-carni-
tine would generate ATP, thereby reversing H2O2-
initiated depletion of ATP in cells and attenuating cell
injury. ATP was considered to be a critical event in lethal
cell injury produced by oxygen radicals [33]. The hypoth-
eses need further investigation.
It has been reported that PPAR-a gene expression is
associated with SOD gene expression in the liver [20],
and CAT has been identified as one of the target
enzymes of PPAR-a [34]. In the present study, the up-
regulation of SOD and CAT expression by L-carnitine
were attenuated by PPAR-a antagonist MK886. The
results reveal the crucial role of PPAR-a activation in
the protective effect of L-carnitine against H2O2-induced
damage in HL7702 cells. L-carnitine might elevate
Figure 6 Effect of L-carnitine on expression levels of PPAR-a and its target genes in H2O2-treated HL7702 cells. HL7702 cells were
pretreated with L-carnitine for 12 h and followed by the treatment of H2O2 (300 μM) for 12 h. A: Cells were collected, total RNA and protein
were prepared to determine the mRNA and protein levels of PPAR-a in HL7702 cells using RT-PCR and western blot analysis respectively. B: Total
RNA was extracted and expressions of CPT1 and ACOX were quantified using RT-PCR. The data was normalized to GAPDH expression. Each value
represents the mean of three replicates.
#P < 0.01 vs. control; *P < 0.05, **P < 0.01 vs.H 2O2 alone.
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resulting in a decrease in extracellular H2O2 levels and
prevention of liver damage.
Conclusions
Taken together, the present results provide evidence
that L-carnitine prevented in vitro human hepatocyte
oxidative stress induced by H2O2. The protective effects
of L-carnitine observed in the current paper can possi-
bly be mediated through its antioxidant potential. The
elevated PPAR-a expression by L-carnitine play an
important part in the protective effect, which might
contribute to the amelioration of lipid homeostasis, the
improvement of antioxidant ability, and increased ATP
in L-carnitine treated cells.
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